Tscan Therapeutics Stock Price History

TCRX Stock  USD 1.82  0.07  3.70%   
If you're considering investing in Tscan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tscan Therapeutics stands at 1.82, as last reported on the 21st of July, with the highest price reaching 1.91 and the lowest price hitting 1.81 during the day. Tscan Therapeutics appears to be very risky, given 3 months investment horizon. Tscan Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0683, which indicates the firm had a 0.0683 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Tscan Therapeutics, which you can use to evaluate the volatility of the company. Please review Tscan Therapeutics' Risk Adjusted Performance of 0.1264, semi deviation of 4.23, and Coefficient Of Variation of 791.35 to confirm if our risk estimates are consistent with your expectations.
At this time, Tscan Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 117.6 M in 2025, whereas Common Stock Total Equity is likely to drop 2,565 in 2025. . At this time, Tscan Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.17 in 2025, whereas Price To Sales Ratio is likely to drop 86.63 in 2025. Tscan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0683

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsTCRX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.91
  actual daily
52
52% of assets are less volatile

Expected Return

 0.4
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Tscan Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tscan Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.49
Enterprise Value Ebitda
0.3916
Price Sales
23.2967
Shares Float
40.7 M
Wall Street Target Price
9

Tscan Therapeutics Stock Price History Chart

There are several ways to analyze Tscan Stock price data. The simplest method is using a basic Tscan candlestick price chart, which shows Tscan Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJuly 14, 20251.92
Lowest PriceMay 20, 20251.21

Tscan Therapeutics July 21, 2025 Stock Price Synopsis

Various analyses of Tscan Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Tscan Stock. It can be used to describe the percentage change in the price of Tscan Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Tscan Stock.
Tscan Therapeutics Price Rate Of Daily Change 0.96 
Tscan Therapeutics Price Daily Balance Of Power(0.70)
Tscan Therapeutics Price Action Indicator(0.07)

Tscan Therapeutics July 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Tscan Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Tscan Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Tscan Stock and then apply it to test your longer-term investment strategies against Tscan.

Tscan Stock Price History Data

The price series of Tscan Therapeutics for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 0.71 with a coefficient of variation of 11.94. The price distribution for the period has arithmetic mean of 1.53. The median price for the last 90 days is 1.51. The company had dividends distributed to its stock-holders on September 13, 2018.
OpenHighLowCloseVolume
07/21/2025
 1.90  1.91  1.81  1.82 
07/18/2025
 1.90  1.91  1.81  1.82  177,988 
07/17/2025
 1.82  1.94  1.80  1.89  380,357 
07/16/2025
 1.79  1.86  1.76  1.81  304,476 
07/15/2025
 1.91  1.91  1.75  1.77  314,442 
07/14/2025
 1.79  1.94  1.77  1.92  270,869 
07/11/2025 1.84  1.86  1.76  1.81  228,621 
07/10/2025
 1.84  1.88  1.75  1.84  231,720 
07/09/2025
 1.72  1.90  1.72  1.84  501,370 
07/08/2025
 1.48  1.73  1.46  1.70  701,411 
07/07/2025
 1.51  1.54  1.45  1.45  342,509 
07/03/2025
 1.48  1.53  1.47  1.51  185,958 
07/02/2025
 1.46  1.54  1.45  1.47  223,003 
07/01/2025
 1.46  1.54  1.43  1.43  296,002 
06/30/2025
 1.40  1.51  1.40  1.45  458,042 
06/27/2025
 1.49  1.53  1.40  1.40  5,400,503 
06/26/2025
 1.57  1.59  1.45  1.48  383,615 
06/25/2025 1.69  1.69  1.54  1.54  509,047 
06/24/2025
 1.49  1.73  1.46  1.68  586,115 
06/23/2025
 1.41  1.53  1.41  1.45  464,426 
06/20/2025
 1.46  1.48  1.39  1.44  449,539 
06/18/2025
 1.55  1.60  1.46  1.46  273,225 
06/17/2025
 1.50  1.61  1.45  1.54  450,410 
06/16/2025
 1.54  1.57  1.44  1.53  435,841 
06/13/2025
 1.60  1.64  1.52  1.55  194,527 
06/12/2025
 1.58  1.69  1.55  1.61  253,252 
06/11/2025
 1.72  1.79  1.57  1.60  496,604 
06/10/2025
 1.78  1.87  1.69  1.69  291,262 
06/09/2025
 1.85  1.86  1.69  1.77  311,368 
06/06/2025 1.68  1.83  1.66  1.80  213,358 
06/05/2025
 1.79  1.79  1.66  1.68  211,454 
06/04/2025
 1.74  1.81  1.67  1.78  410,874 
06/03/2025
 1.45  1.75  1.43  1.75  1,180,115 
06/02/2025
 1.43  1.49  1.41  1.46  528,936 
05/30/2025
 1.47  1.48  1.39  1.43  443,333 
05/29/2025
 1.45  1.49  1.42  1.47  412,604 
05/28/2025 1.44  1.48  1.41  1.45  369,502 
05/27/2025
 1.41  1.45  1.33  1.43  1,076,520 
05/23/2025 1.42  1.44  1.37  1.38  550,448 
05/22/2025
 1.43  1.50  1.37  1.44  1,079,716 
05/21/2025
 1.23  1.33  1.17  1.32  2,506,157 
05/20/2025 1.23  1.26  1.16  1.21  3,926,435 
05/19/2025 1.21  1.30  1.19  1.24  2,000,914 
05/16/2025
 1.30  1.33  1.23  1.24  311,646 
05/15/2025
 1.29  1.33  1.24  1.31  300,571 
05/14/2025
 1.32  1.46  1.22  1.28  272,557 
05/13/2025
 1.37  1.42  1.30  1.33  221,396 
05/12/2025 1.35  1.39  1.27  1.37  317,881 
05/09/2025
 1.37  1.43  1.27  1.27  244,572 
05/08/2025 1.36  1.44  1.34  1.38  190,188 
05/07/2025 1.37  1.47  1.36  1.36  235,729 
05/06/2025 1.47  1.48  1.32  1.36  392,896 
05/05/2025
 1.56  1.59  1.49  1.50  185,071 
05/02/2025
 1.58  1.65  1.56  1.60  348,423 
05/01/2025
 1.60  1.61  1.50  1.55  160,090 
04/30/2025
 1.55  1.65  1.48  1.61  288,677 
04/29/2025
 1.58  1.65  1.56  1.59  305,797 
04/28/2025
 1.60  1.63  1.55  1.60  260,194 
04/25/2025
 1.70  1.71  1.57  1.60  258,497 
04/24/2025
 1.61  1.73  1.58  1.72  377,010 
04/23/2025
 1.59  1.67  1.55  1.63  415,061 

About Tscan Therapeutics Stock history

Tscan Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tscan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tscan Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tscan Therapeutics stock prices may prove useful in developing a viable investing in Tscan Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding112 M117.6 M
Net Loss-59.6 M-62.6 M

Tscan Therapeutics Quarterly Net Working Capital

225.02 Million

Tscan Therapeutics Stock Technical Analysis

Tscan Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tscan Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tscan Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Tscan Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Tscan Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tscan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tscan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Tscan Stock Analysis

When running Tscan Therapeutics' price analysis, check to measure Tscan Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tscan Therapeutics is operating at the current time. Most of Tscan Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tscan Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tscan Therapeutics' price. Additionally, you may evaluate how the addition of Tscan Therapeutics to your portfolios can decrease your overall portfolio volatility.